Back to VA VANGUARD CAPITAL MANAGEMENT LLC

FATEFATE
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in FATE THERAPEUTICS INC

Yes. Vanguard Capital Management holds 4,445,536 shares of FATE (Fate Therapeutics), worth $12M, as of its Q2 2026 13F filing. It increased the position by 253,473 shares (+6.1%) from Q1 2026. Vanguard Capital Management has held FATE in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$12M

Current Shares

4.4M

Total Value Change

+$7M

Total Shares Change

+253,473

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.4M
+6.0%
$12M0.0%$2.70
30
2026-Q1
First report
4.2M
-
$5M0.0%$1.20
0

Other major holders of FATE: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used